South Cone Investments Limited Partnership bought $11M of RANI
owner at Rani Therapeutics Holdings, Inc.. 5,265,165 shares at an average of $2.01, traded Nov 24, 2023, filed Dec 8, 2023.
Score components
- +12Role10% owner
- +25Trade size$10.6M at market
- +10Relative to holdingsHoldings up 77%
- +18Price context9% above the 52-week low; 76% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-23-124719, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 24, 2023 | POpen-market purchase Class A Common Stockindirect: Shares indirectly held through South Lake One LLC | +5,265,165 | $2.01 | $11M | 12,131,554 | Dec 8, 2023 |
Related signals
Other insiders at Rani Therapeutics Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | Rani Therapeutics Holdings, Inc. | Mir A Imran director, owner | $25k 36,000 shares | +2% | |
| 25Weak | RANIsell Rani Therapeutics Holdings, Inc. | Talat Imran Chief Executive Officer | $11k 8,014 shares | -2% | |
| 49Moderate | Rani Therapeutics Holdings, Inc. | Talat Imran Chief Executive Officer | $25k 35,000 shares | +8% | |
| 15Weak | RANIsell Rani Therapeutics Holdings, Inc. | Alireza Javadi Chief Technical Officer | $301 386 shares | -4% | |
| 52Moderate | RANIbuy Rani Therapeutics Holdings, Inc. | Mir A Imran director, owner | $1.3M 2,083,334 shares | - | |
| 57Moderate | RANIsell Rani Therapeutics Holdings, Inc. | South Cone Investments Limited Partnership owner | $16M 5,923,000 shares | -71% | |
| 36Weak | Rani Therapeutics Holdings, Inc. | Kate McKinley Chief Business Officer | $30k 17,960 shares | - | |
| 33Weak | Rani Therapeutics Holdings, Inc. | Talat Imran Chief Executive Officer | $20k 10,296 shares | +2% | |
| 47Moderate | RANIsell Rani Therapeutics Holdings, Inc. | South Cone Investments Limited Partnership owner | $10M 3,829,360 shares | -32% | |
| 57Moderate | RANIsell Rani Therapeutics Holdings, Inc. | Cortes Isidoro Alfonso Quiroga owner | $11M 5,265,165 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.